Amgen AMGN Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 68.3%+1.0pp | 67.2%+1.1pp | 66.2%+1.7pp | 64.5%+1.5pp | 63%+1.5pp | |
| Operating margin | 28.4%+3.7pp | 24.7%+0.6pp | 24.1%+0.6pp | 23.5%+1.6pp | 21.8%+0.1pp | |
| Net margin | 21%0.0pp | 21%+1.5pp | 19.5%+0.5pp | 19%+1.6pp | 17.4%+5.1pp | |
| EBITDA margin | 41.5%+2.8pp | 38.8%-0.4pp | 39.2%-0.1pp | 39.3%+1.1pp | 38.2%-0.3pp | |
| Free cash flow margin | 23.1%+1.1pp | 22%-10.0pp | 32.1%+1.7pp | 30.4%-1.6pp | 32%+0.9pp | |
| Returns | ||||||
| Return on equity | 101.3%-4.8pp | 106.1%+24.4pp | 81.7%-17.4pp | 99.1%-6.5pp | 105.7%+38.1pp | |
| Return on assets | 8.6%+0.1pp | 8.5%+0.7pp | 7.7%+0.3pp | 7.4%+0.9pp | 6.5%+2.2pp | |
| Return on invested capital | 14.1%+2.0pp | 12%+0.8pp | 11.3%+0.1pp | 11.1%+1.0pp | 10.1%+0.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Inventory turnover | 1.8×0.0× | 1.8×0.0× | 1.8×+0.1× | 1.7×+0.1× | 1.6×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.3×+0.1× | 1.1×-0.1× | 1.3×0.0× | 1.3×+0.1× | 1.2×-0.1× | |
| Quick ratio | 1×+0.1× | 0.9×-0.1× | 1×0.0× | 1×+0.1× | 0.9×-0.1× | |
| Cash ratio | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 6.2×-0.2× | 6.4×+0.7× | 5.7×-1.9× | 7.6×-1.7× | 9.2×-1.1× | |
| Debt-to-assets | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | |
| Net debt / EBITDA | 3.7×-0.2× | 3.8×0.0× | 3.8×-0.2× | 4.1×-0.3× | 4.4×-0.3× | |
| Interest coverage | 3.9×+0.6× | 3.3×+0.3× | 3×+0.3× | 2.8×+0.3× | 2.4×+0.1× | |
| Per Share | ||||||
| Book value per share | $16.89+5.8% | $15.97-10.0% | $17.75+29.3% | $13.73+19.7% | $11.47+5.6% | |
| Valuation | ||||||
| Market capitalization | $189.67B+7.6% | $176.25B+16.0% | $151.93B+1.8% | $149.21B-10.8% | $167.37B+19.5% | |
| Enterprise value | $246.43B+6.6% | $231.08B+12.3% | $205.78B+0.4% | $204.87B-8.6% | $224.24B+11.8% | |
| Price / earnings | 24.3×+1.5× | 22.9×+1.2× | 21.7×-0.9× | 22.5×-5.7× | 28.2×-6.0× | |
| Price / sales | 5.1×+0.3× | 4.8×+0.6× | 4.2×0.0× | 4.3×-0.6× | 4.9×+0.7× | |
| Price / book | 20.6×+0.3× | 20.4×+4.6× | 15.8×-4.3× | 20.1×-6.9× | 27×+3.1× | |
| EV / EBITDA | 15.9×-0.3× | 16.2×+1.6× | 14.6×-0.3× | 14.9×-2.3× | 17.2×+1.6× | |
| EV / sales | 6.6×+0.3× | 6.3×+0.6× | 5.7×-0.1× | 5.9×-0.7× | 6.6×+0.6× | |
| Free cash flow yield | 4.5%-0.1pp | 4.6%-3.0pp | 7.6%+0.5pp | 7.1%+0.6pp | 6.5%-0.9pp | |
| Earnings yield | 4.1%-0.3pp | 4.4%-0.2pp | 4.6%+0.2pp | 4.4%+0.9pp | 3.5%+0.6pp | |
| Dividend yield | 2.7%-0.2pp | 2.9%-0.4pp | 3.3%0.0pp | 3.3%+0.4pp | 2.9%-0.5pp | |
| PEG ratio | 0.8×+0.5× | 0.3×-0.1× | 0.3×+0.1× | 0.2×-0.3× | 0.5×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amgen's profit margins?
- Amgen (AMGN) runs a 68.3% gross margin and a 28.4% operating margin, with a 21.0% net margin.
- Where do Amgen's ratios come from?
- Every ratio is computed from Amgen's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
